Evidence map›Paper›PMID 27515179›Full record

Observational studyBMC anesthesiology2016

Hypoxia inducible factor-1 alpha and prolinhydroxlase 2 polymorphisms in patients with severe sepsis: a prospective observational trial.

Annika Höcker, Miriam Rabeling, Alexandra Bick, Linda Cox, Maximiliane Kreuzer, Andrea Engler, Kai Walstein, Hagen S Bachmann, Karl-Heinz Jöckel, Lewin Eisele and 3 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC anesthesiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Protective association of theFrontiers in medicine · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Immunometabolism and Sepsis: A Role for HIF?Frontiers in molecular biosciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Annika HöckerKlinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen and Universität Duisburg-Essen, Hufelandstraße 55, D-45122, Essen, Germany.
Miriam RabelingKlinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen and Universität Duisburg-Essen, Hufelandstraße 55, D-45122, Essen, Germany.
Alexandra BickKlinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen and Universität Duisburg-Essen, Hufelandstraße 55, D-45122, Essen, Germany.
Linda CoxKlinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen and Universität Duisburg-Essen, Hufelandstraße 55, D-45122, Essen, Germany.
Maximiliane KreuzerKlinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen and Universität Duisburg-Essen, Hufelandstraße 55, D-45122, Essen, Germany.
Andrea EnglerKlinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen and Universität Duisburg-Essen, Hufelandstraße 55, D-45122, Essen, Germany.
Kai WalsteinKlinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen and Universität Duisburg-Essen, Hufelandstraße 55, D-45122, Essen, Germany.
Hagen S BachmannInstitut für Pharmakogenetik, Universitätsklinikum Essen and Universität Duisburg-Essen, Essen, Germany.
Karl-Heinz JöckelInstitut für Medizinische Informatik, Biometrie und Epidemiologie, Universitätsklinikum Essen and Universität Duisburg-Essen, Essen, Germany.
Lewin EiseleInstitut für Medizinische Informatik, Biometrie und Epidemiologie, Universitätsklinikum Essen and Universität Duisburg-Essen, Essen, Germany.
Michael AdamzikKlinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen and Universität Duisburg-Essen, Hufelandstraße 55, D-45122, Essen, Germany.
Jürgen PetersKlinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen and Universität Duisburg-Essen, Hufelandstraße 55, D-45122, Essen, Germany.
Simon T SchäferKlinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen and Universität Duisburg-Essen, Hufelandstraße 55, D-45122, Essen, Germany. simon.schaefer@uk-essen.de.
Essen University Hospital · DEUniversity of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHypoxia-inducible-factor-1α (HIF-1α) and HIF-1 degrading prolyl-hydroxylases (PHD) are key regulators of the hypoxic-inflammatory response. Functionally active genetic variants in the HIF-1α (C/T; Single Nucleotide Polymorphism (SNP) rs11549465) and the PHD2 gene (EGLN1; C/T; SNP rs516651 and T/C; SNP rs480902) are associated with altered HIF-1α mRNA nuclear translocation and an altered adaptation to hypoxia. Furthermore, the HIF system is important in surviving inflammatory disorders and sepsis. Thus, we tested the hypotheses, that SNPs in the HIF-1α or PHD2 genes are (1) common in Caucasians, with 2) the HIF-1α genetic variant being associated with an altered HIF-1α mRNA expression; and 3) independent risk factors for 30-day mortality in severe sepsis.

methodsAfter ethics approval, 128 septic patients (Caucasian descent) were included prospectively within 24 h after first diagnosing sepsis. Patients characteristics and severity of illness (simplified acute physiology score II), genotypes (Taqman assay), and their influence on leukocyte HIF-1α-mRNA-expression (Real-Time PCR) and 30-day mortality were determined.

resultsFrequencies were 0.8 % for homozygous HIF-1α TT-carriers (CT 17.6 %; CC 81.6 %), 2.5 % for homozygous PHD2 SNP rs516651 TT-allele carriers (CT 17.5 % and CC 80 %), and 9.4 % for homozygous PHD2 SNP rs480902 TT-allele carriers (CT 34.4 % and CC 56.3 %). While HIF-1α T-allele carriers had a borderline decrease in HIF-1α-mRNA-expression (p = 0.06) neither HIF-1α nor PHD2 SNPs were (independent) risk factors for 30-day mortality.

conclusionsGenetic variants in HIF-1α and PHD2 genes exist in Caucasians but do not appear to alter 30-day mortality in sepsis.

Indexed as

Genetic VariationAgedFemaleGenotypeHumansHypoxia-Inducible Factor 1, alpha SubunitHypoxia-Inducible Factor-Proline DioxygenasesMaleMiddle AgedPolymorphism, Single NucleotideProspective StudiesReal-Time Polymerase Chain ReactionRisk FactorsRNA, MessengerSepsisSeverity of Illness IndexEGLN1 protein, humanHypoxia-Inducible Factor 1, alpha SubunitHypoxia-Inducible Factor-Proline DioxygenasesRNA, MessengerGenetic variantsHIFHypoxia inducible factorPolymorphismSepsis

Identifiers

PMID27515179
PMCPMC4982006
OpenAlexW2517474114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.